Antenatal Opioid Exposure is Associated with Punctate White Matter Lesions in Term Infants
Saturday, May 4, 2024
11:00 AM – 11:15 AM ET
Location: Metro Toronto Convention Centre: 202
CE Enduring CME: 0.25
Publication Number: 3060.1
Stephanie L. Merhar, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States; Catherine Limperopoulos, Children's Hospital & Medical Center, Washington DC, DC, United States; Sara B. DeMauro, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States; Nicole Mack, RTI International, Durham, NC, United States; Carla Bann, RTI International, Research Triangle Park, NC, United States; Namasivayam Ambalavanan, University of Alabama School of Medicine, Birmingham, AL, United States; Scott A. Lorch, The, Philadelphia, PA, United States; Jonathan M. Davis, Tufts University School of Medicine, Boston, MA, United States; Jamie E. Newman, RTI International, Carrboro, NC, United States; Deanne Wilson-Costello, UH Rainbow Babies & Children's Hospital, Cleveland, OH, United States; Brenda Poindexter, Emory University and Children's Healthcare of Atlanta, Atlanta, GA, United States; Myriam Peralta-Carcelen, University of Alabama School of Medicine, Birmingham, AL, United States; Michele Walsh, NICHD, Bethesda, MD, United States; Beth M. Kline-Fath, Cincinnati Children's, Dayton, OH, United States; Jonathan Murnick, Children's National Health System, Washington, DC, United States
Presenting Author(s)
SM
Stephanie L. Merhar, MD MS (she/her/hers)
Associate Professor of Pediatrics Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States